Exact Mass: 486.18139140000005
Exact Mass Matches: 486.18139140000005
Found 500 metabolites which its exact mass value is equals to given mass value 486.18139140000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Rutaevin
Rutaevin is a steroid lactone. Rutaevin is a natural product found in Fagaropsis angolensis, Tetradium glabrifolium, and other organisms with data available.
isonocardicin C
A monobactam that is produced by Nocardia uniformis subsp. tsuyamanensis.
OTSSP167
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside is from Fusarium sulphureu From Fusarium sulphureum
Glucosylgalactosyl hydroxylysine
Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences. The hydroxylysine residues formed in the lysyl hydroxylase reaction have 2 important functions: first, their hydroxy groups serve as sites of attachment for carbohydrate units, either the monosaccharide galactose or the disaccharide glucosylgalactose; and second, they are essential for the stability of the intermolecular collagen crosslinks. (OMIM 153454). Hydroxylysine-deficient skin collagen is manifested in Ehlers-Danlos syndrome, type VIA, A heritable disorder of connective tissue (PMID 5016372). Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences.
2-O-alpha-D-Glucopyranosyl-O-beta-D-galactopyranosylhydroxylysine
2-[[5-[3-(Dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione
N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
C26H26N6O4 (486.20154360000004)
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].
1-(3,4-Dimethoxyphenyl)-2,3-bis(methoxycarbonyl)-4-hydroxy-6,7,8-trimethoxynaphthalene
C25H26O10 (486.15258960000006)
Catharanthine tartrate
C21H24N2O2.C4H6O6 (486.200206)
4-[6-[(6-O-Acetyl-beta-D-glucopyranosyl)oxy]-3-methyl-2-oxohexyl]dihydro-3-methylene-5-(2-oxopropyl)-2(3H)-furanone
Artelastochromene
alpha-D-glucopyranuronosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->2)-alpha-rhamnopyranose
O6-(O6-beta-D-Fructofuranosyl-beta-D-fructofuranosyl)-1,2-anhydro-beta-D-fructofuranose
5beta-hydroxy-1-O-(6-O-p-hydroxybenzoyl)-beta-D-glucopyranosyl eucommiol
6-O-(4-methoxybenzoyl)crescentin IV 3-O-beta-D-glucopyranoside
2-allyl-4,5-methylenedioxyphenol-1-O-alpha-L-rhamnopyranosyl-(1<*>6)-O-beta-D-glucopyranoside|2-allyl-4,5-methylenedioxyphenol-1-O-alpha-L-rhamnopyranosyl-(1[*]6)-O-beta-D-glucopyranoside
1-(4-beta-D-glucopyranosyloxybenzyl) 4-ethyl (2R)-2-isobutylmalate
2-(10,11-dihydroxy-1-bibenzyl-oxy)-1-methoxy-6,10,11-trihydroxy-7,8-dihydro-phenanthrene
Bufa-20,22-dienolide,1,3,5-[(1R)-ethylidynetris(oxy)]-11,14-dihydroxy-12,19-dioxo-, (1b,3b,5b,11a)- (9CI)
1-O-beta-D-fructofuranosyl di-D-fructofuranose beta2,6:beta2,6 dianhydride
callophycoic acid A
C27H35BrO3 (486.17694200000005)
A dibenzooxepine diterpenoid that is hexahydrodibenzo[b,e]oxepine with an isolated double bond between positions 6a and 7 and is substituted by a bromo, a carboxy, a 3E-4,8-dimethylnona-3,7-dien-1-yl and a methyl group at positions 9, 2, 10 and 10 respectively (the 9S,10S,10aR stereoisomer). It is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.
(R)-Vittatolic acid|3,8-dihydroxy-1-(4-hydroxy-2-oxo-heptyl)-11-oxo-6-pentyl-11H-dibenzo[b,e][1,4]dioxepine-7-carboxylic acid|Vittatolinsaeure|Vittatolsaeure
1-[3,4-dihydroxy-5-(trityloxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
callophycoic acid B
C27H35BrO3 (486.17694200000005)
A dibenzooxepine diterpenoid that is hexahydrodibenzo[b,e]oxepine with an isolated double bond between positions 6 and 6a and is substituted by a bromo, a carboxy, a 3E-4,8-dimethylnona-3,7-dien-1-yl and a methyl group at positions 9, 2, 10 and 10 respectively (the 9S,10S,10aR stereoisomer). An isomer of callophycoic acid A, it is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.
Khadanin B
Kihadanin B is a natural product found in Phellodendron amurense and Trichilia elegans with data available.
Catharanthine tartrate
Ala Cys Phe Phe
Ala Cys Met Tyr
Ala Cys Tyr Met
Ala Glu His Met
Ala Glu Met His
Ala Phe Cys Phe
Ala Phe Phe Cys
Ala His Glu Met
Ala His Met Glu
Ala Met Cys Tyr
Ala Met Glu His
Ala Met His Glu
Ala Met Tyr Cys
Ala Tyr Cys Met
Ala Tyr Met Cys
Cys Ala Phe Phe
Cys Ala Met Tyr
Cys Ala Tyr Met
Cys Cys Val Tyr
Cys Cys Tyr Val
Cys Asp His Ile
Cys Asp His Leu
Cys Asp Ile His
Cys Asp Leu His
Cys Glu His Val
Cys Glu Val His
Cys Phe Ala Phe
Cys Phe Phe Ala
Cys Phe Met Ser
Cys Phe Ser Met
Cys His Asp Ile
Cys His Asp Leu
Cys His Glu Val
Cys His Ile Asp
Cys His Leu Asp
Cys His Met Pro
Cys His Asn Asn
C17H26N8O7S (486.16450860000003)
Cys His Pro Met
Cys His Val Glu
Cys Ile Asp His
Cys Ile His Asp
Cys Leu Asp His
Cys Leu His Asp
Cys Met Ala Tyr
Cys Met Phe Ser
Cys Met His Pro
Cys Met Pro His
Cys Met Ser Phe
Cys Met Tyr Ala
Cys Asn His Asn
C17H26N8O7S (486.16450860000003)
Cys Asn Asn His
C17H26N8O7S (486.16450860000003)
Cys Pro His Met
Cys Pro Met His
Cys Ser Phe Met
Cys Ser Met Phe
Cys Thr Thr Tyr
Cys Thr Tyr Thr
Cys Val Cys Tyr
Cys Val Glu His
Cys Val His Glu
Cys Val Tyr Cys
Cys Tyr Ala Met
Cys Tyr Cys Val
Cys Tyr Met Ala
Cys Tyr Thr Thr
Cys Tyr Val Cys
Asp Cys His Ile
Asp Cys His Leu
Asp Cys Ile His
Asp Cys Leu His
Asp Asp His Thr
Asp Asp Thr His
Asp Glu His Ser
Asp Glu Ser His
Asp His Cys Ile
Asp His Cys Leu
Asp His Asp Thr
Asp His Glu Ser
Asp His Ile Cys
Asp His Leu Cys
Asp His Ser Glu
Asp His Thr Asp
Asp Ile Cys His
Asp Ile His Cys
Asp Leu Cys His
Asp Leu His Cys
Asp Pro Gln Gln
C19H30N6O9 (486.20741699999996)
Asp Gln Pro Gln
C19H30N6O9 (486.20741699999996)
Asp Gln Gln Pro
C19H30N6O9 (486.20741699999996)
Asp Ser Glu His
Asp Ser His Glu
Asp Thr Asp His
Asp Thr His Asp
Glu Ala His Met
Glu Ala Met His
Glu Cys His Val
Glu Cys Val His
Glu Asp His Ser
Glu Asp Ser His
Glu His Ala Met
Glu His Cys Val
Glu His Asp Ser
Glu His Met Ala
Glu His Ser Asp
Glu His Thr Thr
C19H30N6O9 (486.20741699999996)
Glu His Val Cys
Glu Met Ala His
Glu Met His Ala
Glu Asn Pro Gln
C19H30N6O9 (486.20741699999996)
Glu Asn Gln Pro
C19H30N6O9 (486.20741699999996)
Glu Pro Asn Gln
C19H30N6O9 (486.20741699999996)
Glu Pro Gln Asn
C19H30N6O9 (486.20741699999996)
Glu Gln Asn Pro
C19H30N6O9 (486.20741699999996)
Glu Gln Pro Asn
C19H30N6O9 (486.20741699999996)
Glu Ser Asp His
Glu Ser His Asp
Glu Thr His Thr
C19H30N6O9 (486.20741699999996)
Glu Thr Thr His
C19H30N6O9 (486.20741699999996)
Glu Val Cys His
Glu Val His Cys
Phe Ala Cys Phe
Phe Ala Phe Cys
Phe Cys Ala Phe
Phe Cys Phe Ala
Phe Cys Met Ser
Phe Cys Ser Met
Phe Phe Ala Cys
Phe Phe Cys Ala
Phe Met Cys Ser
Phe Met Ser Cys
Phe Ser Cys Met
Phe Ser Met Cys
Gly His His His
C20H26N10O5 (486.2087546000001)
His Ala Glu Met
His Ala Met Glu
His Cys Asp Ile
His Cys Asp Leu
His Cys Glu Val
His Cys Ile Asp
His Cys Leu Asp
His Cys Met Pro
His Cys Asn Asn
C17H26N8O7S (486.16450860000003)
His Cys Pro Met
His Cys Val Glu
His Asp Cys Ile
His Asp Cys Leu
His Asp Asp Thr
His Asp Glu Ser
His Asp Ile Cys
His Asp Leu Cys
His Asp Ser Glu
His Asp Thr Asp
His Glu Ala Met
His Glu Cys Val
His Glu Asp Ser
His Glu Met Ala
His Glu Ser Asp
His Glu Thr Thr
C19H30N6O9 (486.20741699999996)
His Glu Val Cys
His Gly His His
C20H26N10O5 (486.2087546000001)
His His Gly His
C20H26N10O5 (486.2087546000001)
His His His Gly
C20H26N10O5 (486.2087546000001)
His Ile Cys Asp
His Ile Asp Cys
His Leu Cys Asp
His Leu Asp Cys
His Met Ala Glu
His Met Cys Pro
His Met Glu Ala
His Met Pro Cys
His Asn Cys Asn
C17H26N8O7S (486.16450860000003)
His Asn Asn Cys
C17H26N8O7S (486.16450860000003)
His Pro Cys Met
His Pro Met Cys
His Ser Asp Glu
His Ser Glu Asp
His Thr Asp Asp
His Thr Glu Thr
C19H30N6O9 (486.20741699999996)
His Thr Thr Glu
C19H30N6O9 (486.20741699999996)
His Val Cys Glu
His Val Glu Cys
Ile Cys Asp His
Ile Cys His Asp
Ile Asp Cys His
Ile Asp His Cys
Ile His Cys Asp
Ile His Asp Cys
Leu Cys Asp His
Leu Cys His Asp
Leu Asp Cys His
Leu Asp His Cys
Leu His Cys Asp
Leu His Asp Cys
Met Ala Cys Tyr
Met Ala Glu His
Met Ala His Glu
Met Ala Tyr Cys
Met Cys Ala Tyr
Met Cys Phe Ser
Met Cys His Pro
Met Cys Pro His
Met Cys Ser Phe
Met Cys Tyr Ala
Met Glu Ala His
Met Glu His Ala
Met Phe Cys Ser
Met Phe Ser Cys
Met His Ala Glu
Met His Cys Pro
Met His Glu Ala
Met His Pro Cys
Met Pro Cys His
Met Pro His Cys
Met Ser Cys Phe
Met Ser Phe Cys
Met Ser Ser Tyr
Met Ser Tyr Ser
Met Tyr Ala Cys
Met Tyr Cys Ala
Met Tyr Ser Ser
Asn Cys His Asn
C17H26N8O7S (486.16450860000003)
Asn Cys Asn His
C17H26N8O7S (486.16450860000003)
Asn Glu Pro Gln
C19H30N6O9 (486.20741699999996)
Asn Glu Gln Pro
C19H30N6O9 (486.20741699999996)
Asn His Cys Asn
C17H26N8O7S (486.16450860000003)
Asn His Asn Cys
C17H26N8O7S (486.16450860000003)
Asn Asn Cys His
C17H26N8O7S (486.16450860000003)
Asn Asn His Cys
C17H26N8O7S (486.16450860000003)
Asn Pro Glu Gln
C19H30N6O9 (486.20741699999996)
Asn Pro Gln Glu
C19H30N6O9 (486.20741699999996)
Asn Gln Glu Pro
C19H30N6O9 (486.20741699999996)
Asn Gln Pro Glu
C19H30N6O9 (486.20741699999996)
Pro Cys His Met
Pro Cys Met His
Pro Asp Gln Gln
C19H30N6O9 (486.20741699999996)
Pro Glu Asn Gln
C19H30N6O9 (486.20741699999996)
Pro Glu Gln Asn
C19H30N6O9 (486.20741699999996)
Pro His Cys Met
Pro His Met Cys
Pro Met Cys His
Pro Met His Cys
Pro Asn Glu Gln
C19H30N6O9 (486.20741699999996)
Pro Asn Gln Glu
C19H30N6O9 (486.20741699999996)
Pro Gln Asp Gln
C19H30N6O9 (486.20741699999996)
Pro Gln Glu Asn
C19H30N6O9 (486.20741699999996)
Pro Gln Asn Glu
C19H30N6O9 (486.20741699999996)
Pro Gln Gln Asp
C19H30N6O9 (486.20741699999996)
Gln Asp Pro Gln
C19H30N6O9 (486.20741699999996)
Gln Asp Gln Pro
C19H30N6O9 (486.20741699999996)
Gln Glu Asn Pro
C19H30N6O9 (486.20741699999996)
Gln Glu Pro Asn
C19H30N6O9 (486.20741699999996)
Gln Asn Glu Pro
C19H30N6O9 (486.20741699999996)
Gln Asn Pro Glu
C19H30N6O9 (486.20741699999996)
Gln Pro Asp Gln
C19H30N6O9 (486.20741699999996)
Gln Pro Glu Asn
C19H30N6O9 (486.20741699999996)
Gln Pro Asn Glu
C19H30N6O9 (486.20741699999996)
Gln Pro Gln Asp
C19H30N6O9 (486.20741699999996)
Gln Gln Asp Pro
C19H30N6O9 (486.20741699999996)
Gln Gln Pro Asp
C19H30N6O9 (486.20741699999996)
Ser Cys Phe Met
Ser Cys Met Phe
Ser Asp Glu His
Ser Asp His Glu
Ser Glu Asp His
Ser Glu His Asp
Ser Phe Cys Met
Ser Phe Met Cys
Ser His Asp Glu
Ser His Glu Asp
Ser Met Cys Phe
Ser Met Phe Cys
Ser Met Ser Tyr
Ser Met Tyr Ser
Ser Ser Met Tyr
Ser Ser Tyr Met
Ser Tyr Met Ser
Ser Tyr Ser Met
Thr Cys Thr Tyr
Thr Cys Tyr Thr
Thr Asp Asp His
Thr Asp His Asp
Thr Glu His Thr
C19H30N6O9 (486.20741699999996)
Thr Glu Thr His
C19H30N6O9 (486.20741699999996)
Thr His Asp Asp
Thr His Glu Thr
C19H30N6O9 (486.20741699999996)
Thr His Thr Glu
C19H30N6O9 (486.20741699999996)
Thr Thr Cys Tyr
Thr Thr Glu His
C19H30N6O9 (486.20741699999996)
Thr Thr His Glu
C19H30N6O9 (486.20741699999996)
Thr Thr Tyr Cys
Thr Tyr Cys Thr
Thr Tyr Thr Cys
Val Cys Cys Tyr
Val Cys Glu His
Val Cys His Glu
Val Cys Tyr Cys
Val Glu Cys His
Val Glu His Cys
Val His Cys Glu
Val His Glu Cys
Val Tyr Cys Cys
Tyr Ala Cys Met
Tyr Ala Met Cys
Tyr Cys Ala Met
Tyr Cys Cys Val
Tyr Cys Met Ala
Tyr Cys Thr Thr
Tyr Cys Val Cys
Tyr Met Ala Cys
Tyr Met Cys Ala
Tyr Met Ser Ser
Tyr Ser Met Ser
Tyr Ser Ser Met
Tyr Thr Cys Thr
Tyr Thr Thr Cys
Tyr Val Cys Cys
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
Pyrimido[4,5-g]quinazoline-4,9-dione,1,6-dihydro-5,10-dimethoxy-2,7-bis(phenoxymethyl)- (9CI)
[(2R,3R,4S,5R,6R)-4,6-diacetyloxy-3,5-bis(phenylmethoxy)oxan-2-yl]methyl acetate
[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate
C24H29F3O5S (486.16877000000005)
(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5S)-3,5-dihydroxy-2-(hydroxymethyl)oxan-4-yl]oxy-4-[(2S,3R,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-3,5-diol
Spectinomycin sulfate tetrahydrate
C14H34N2O14S (486.17306640000004)
CHLORO[1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]COPPER(I)
Olmutinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Niobium(5+) potassium 2-propanolate (1:1:6)
C18H42KNbO6 (486.16820920000004)
N-(4-(phenyl-9H-carbazol-3-yl)phenyl)biphenyl-4-aMine
MLN0905
4-[bis(2-methylpropyl)sulfamoyl]-N-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide
1,1,1,2,2,3,3,4,4,5,5,6,6-Tridecafluorooctadec-7-ene
C18H23F13 (486.15920739999996)
(2S)-N-[(1S)-1-carbamoyl-2-{4-[(5S)-1,1,3-trioxo-1$l^{6},2-thiazolidin-5-yl]phenyl}ethyl]-2-acetamido-3-phenylpropanamide
C23H26N4O6S (486.15729760000005)
N-(2-Aminoethyl)-N~2~-{(1s)-1-[4-(Aminosulfonyl)biphenyl-4-Yl]-2,2,2-Trifluoroethyl}-L-Leucinamide
(E)-1-[2-hydroxy-3-(3-methylbut-2-enyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
(2R)-2-azaniumyl-4-{4-[(1R)-1-azaniumyl-2-({(3S)-1-[(R)-carboxylato(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}amino)-2-oxoethyl]phenoxy}butanoate
(2S)-2-amino-4-{4-[(R)-amino({[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl})methyl]phenoxy}butanoate
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (2S,4R)-4-propylpyrrolidine-2-carboxylate
3,4,5-Trihydroxy-6-[1-methyl-4-(8-oxo-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidin-1-ium-1-yl]oxane-2-carboxylic acid
C25H28NO7S+ (486.15863980000006)
3-deamino-3-hydroxykanamycin X
A kanamycin that is kanamycin X in which the 3-amino group has been replaced by a hydroxy group.
[(1S,2R,9R,10R,11S)-10-Hydroxy-1,5-dimethyl-11-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
(2S,3S,3aR,9bR)-1-(1,3-benzodioxol-5-ylmethyl)-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
2-[(3S,6aR,8S,10aR)-1-(3-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
C22H31ClN2O6S (486.15912560000004)
2-[(3S,6aR,8R,10aR)-1-(3-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
C22H31ClN2O6S (486.15912560000004)
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)triazol-1-yl]ethyl]oxan-3-yl]-1-phenylmethanesulfonamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)triazol-1-yl]ethyl]oxan-3-yl]-1-phenylmethanesulfonamide
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
2-[(3R,6aR,8S,10aR)-1-(3-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-piperidin-1-ylethanone
C22H31ClN2O6S (486.15912560000004)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(1R,3S,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
N-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
2-[(3R,6aR,8R,10aR)-1-(3-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
C22H31ClN2O6S (486.15912560000004)
(6R,7S,8R)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-methoxyphenyl)-1-triazolyl]ethyl]-3-oxanyl]-1-phenylmethanesulfonamide
N-[(1R,3R,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-3-[2-[(2,5-difluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1R,3S,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1S,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1R,3R,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclopentylacetamide
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
N-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
N-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
N-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-4-fluoro-N-methylbenzenesulfonamide
C23H32ClFN2O4S (486.17552340000003)
2-[(3S,6aS,8S,10aS)-1-(3-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
C22H31ClN2O6S (486.15912560000004)
2-[(3S,6aS,8R,10aS)-1-(3-chlorophenyl)sulfonyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(1-piperidinyl)ethanone
C22H31ClN2O6S (486.15912560000004)
(2R,3R,3aS,9bS)-1-(1,3-benzodioxol-5-ylmethyl)-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid
(6S,7R,8S)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(2-phenylethynyl)phenyl]-4-(phenylmethyl)sulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one
C28H26N2O4S (486.16131960000007)
(Z)-1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorooctadec-7-ene
C18H23F13 (486.15920739999996)
(1R,9S,10S,11S)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1S,9R,10R,11R)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
Nocardicin C
A monobactam that is produced by Nocardia uniformis subsp. tsuyamanensis.
nocardicin C dizwitterion
An alpha-amino acid zwitterion resulting from a transfer of two protons from the carboxy groups to the amino groups of nocardicin C; major species at pH 7.3.
MRS 1754
C26H26N6O4 (486.20154360000004)
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].
3-(3-methyl-2-butenyl)-4-O-beta-D-glucopyranosyl-4,2-dihydroxychalcone
A member of the class of chalcones that consists of trans-chalcone substituted by hydroxy groups at positions 4 and 2, a prenyl group at position 3 and a beta-D-glucopyranosyloxy group at position 4. Isolated from the stem barks of Maclura tinctoria, it exhibits antioxidant activity.
5-[(alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy]-L-lysine
An O-glycosyl amino acid that is L-lysine in which one of the methylene hydrogens at position 5 has been replaced by an (alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy group.
isonocardicin C dizwitterion
An alpha-amino acid zwitterion resulting from a transfer of two protons from the carboxy groups to the amino groups of isonocardicin C; major species at pH 7.3.
Catharanthine (Tartrate)
Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1]. Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1].